Recall of Blood Pressure Medication
Over 580,000 bottles of blood pressure medication have been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of a potential carcinogenic impurity.
The affected medication, prazosin hydrochloride, is manufactured by Teva Pharmaceuticals in New Jersey. The recall includes bottles of 1mg, 2mg, and 5mg capsules.
- 1 milligram (mg) capsules
- 2 mg capsules
- 5 mg capsules
The FDA reports that certain lots of the medication tested positive for elevated levels of a potential carcinogenic impurity, a byproduct of the manufacturing process.
No one wants to trade high blood pressure for a potentially cancer-causing chemical.
It is essential to consult your physician before stopping the medication, even if you are concerned that your bottles are affected.
Affected bottles can be identified by lot number and expiration date, as outlined in the FDA report.
Author's summary: A recall of blood pressure medication due to carcinogenic impurity.
More News
- Loss to Bucks stunk, but Warriors' Jimmy Butler knows key to returning to 'flowers and daisies'
- Patriots' Rhamondre Stevenson is out for Sunday's game vs Falcons
- Wemby’s Evolution Is Scary: Spurs Phenom Dominates Again, Leaves Heat Defenders Helpless
- Coloradans scramble for help as SNAP suspension looms and food banks ‘just don’t have enough’
- Why Ryan Rollins loved Draymond Green coming for him after Stephen Curry incident
- Riley Green & Ella Langley Notch Second Top 10 Together on Country Airplay Chart
- No Giannis, No Problem — Bucks Take Down Warriors as Antetokounmpo Steals the Show in Minion Costume
- Economy stumbles again, but not enough to spur more BoC cuts - CMT News
- Distorted narratives risk reversing South Caucasus peace progress [OPINION]
- CNN's David Urban Says Dems Are Stoking Fear on Gay Marriage